Real-World Cost-Effectiveness of Oxaliplatin in Stage III Colon Cancer: A Synthesis of Clinical Trial and Daily Practice Evidence.

C.W. van Gils, S de Groot, W.K. Redekop, M. Koopman, C.J. Punt, C.A. de Uyl-Groot, J.G. Coe n van Hasselt

Research output: Contribution to journal › Article › Academic › peer-review

Access to Document

@article{9e21bab33c1a4faaa2dab672d5c7b03b,

title = "Real-World Cost-Effectiveness of Oxaliplatin in Stage III Colon Cancer: A Synthesis of Clinical Trial and Daily Practice Evidence.",

author = "{van Gils}, C.W. and {de Groot}, S and W.K. Redekop and M. Koopman and C.J. Punt and {de Uyl-Groot}, C.A. and {Coe n van Hasselt}, J.G.",

year = "2013",

doi = "10.1007/s40273-013-0061-6.",

language = "English",

volume = "31",

pages = "703--718",

journal = "PharmacoEconomics",

issn = "1170-7690",

publisher = "Adis International Ltd",

number = "8",

}

TY - JOUR

T1 - Real-World Cost-Effectiveness of Oxaliplatin in Stage III Colon Cancer: A Synthesis of Clinical Trial and Daily Practice Evidence.

AU - van Gils, C.W.

AU - de Groot, S

AU - Redekop, W.K.

AU - Koopman, M.

AU - Punt, C.J.

AU - de Uyl-Groot, C.A.

AU - Coe n van Hasselt, J.G.

PY - 2013

Y1 - 2013

U2 - 10.1007/s40273-013-0061-6.

DO - 10.1007/s40273-013-0061-6.

M3 - Article

SN - 1170-7690

VL - 31

SP - 703

EP - 718

JO - PharmacoEconomics

JF - PharmacoEconomics

IS - 8

ER -